Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Excellent performance of CHROMagarTM LIN-R to selectively screen for linezolid-resistant enterococci and staphylococci.

Diagnostic microbiology and infectious disease - 1 Apr 2021

Layer Franziska, Weber Robert E, Fleige Carola, Strommenger Birgit, Cuny Christiane, Werner Guido

Abstract excerpt

The increasing number of nosocomial pathogens with resistances against last resort antibiotics like linezolid leads to a pressing need for the reliable detection of these drug-resistant bacteria. National guidelines on infection prevention, e.g., in Germany, have already recommend screening for linezolid-resistant bacteria, although a corresponding screening agar medium has not been provided. In this study we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Agar
Share to Bacteriological Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enterococcus

Share to Genotype

Share to Linezolid

Share to Staphylococcus

Source

Identifiers

PMID: 33444893
DOI: 10.1016/j.diagmicrobio.2020.115301

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Excellent performance of CHROMagarTM LIN-R to selectively screen for linezolid-resistant enterococci and staphylococci.PMID 33444893Read ↗

Validating a screening agar for linezolid-resistant enterococciSemantic proximity Read ↗

Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015)Semantic proximity Read ↗

The Antibiotic Susceptibilities of Methicilline-Resistant Staphylococcus aureus Strains Isolated From Various Clinical SamplesSemantic proximity Read ↗

Linezolid in the Focus of Antimicrobial Resistance of Enterococcus Species: A Global Overview of Genomic StudiesSemantic proximity Read ↗

Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).Semantic proximity Read ↗

ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countriesSemantic proximity Read ↗

ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries.Semantic proximity Read ↗

Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, ChinaSemantic proximity Read ↗

Phenotypic and genotypic characterization of linezolid resistance and the effect of antibiotic combinations on methicillin-resistant Staphylococcus aureus clinical isolates.Semantic proximity Read ↗

Molecular Characteristics and Antimicrobial Resistance of Linezolid-Resistant Staphylococcus aureus in Osteoarticular Infections: A 11-Year Study From a Hospital in Xi’anSemantic proximity Read ↗

Global Expansion of Linezolid-Resistant Coagulase-Negative StaphylococciSemantic proximity Read ↗

Validation of selective agars for detection and quantification of <i>Escherichia coli</i> resistant to critically important antimicrobialsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.